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Dairy consumption and the risk of 15-year cardiovascular disease mortality in a
cohort of older Australians
Abstract
The effects of habitual dairy consumption and the risk of 15-year cardiovascular disease (CVD) mortality
in a cohort of older Australians were investigated. Participants (n = 2900) completed a validated 145-item
semi-quantitative food frequency questionnaire. Cox proportional hazards regression models were used
to investigate associations between tertiles of the dairy consumption, including low/reduced fat dairy,
whole fat dairy and their ratio (ratioLF/WF), and risk of mortality from coronary heart disease (CHD),
stroke or combined CVD. There were 548 recorded cases of CVD mortality in this cohort. For total dairy
intake, a reduction in risk of CVD was only seen in tertile 2 (adjusted hazard ratio, AHR: 0.71; 95% CI:
0.55-0.93), and for CHD both tertile 2 and tertile 3 were associated with a reduced risk (both with AHR:
0.71). However there were no linear trends between total dairy consumption and any of the three
outcomes. There were no associations or trends between low/reduced fat dairy or whole fat dairy
consumption, or ratioLF/WF and any of the three outcomes in the fully adjusted model (all p > 0.05). This
study found no consistent association between baseline consumption of dairy foods and the risk of CHD,
stroke and combined CVD mortality.
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Abstract: The effects of habitual dairy consumption and the risk of 15-year cardiovascular
disease (CVD) mortality in a cohort of older Australians were investigated. Participants
(n = 2900) completed a validated 145-item semi-quantitative food frequency questionnaire.
Cox proportional hazards regression models were used to investigate associations between
tertiles of the dairy consumption, including low/reduced fat dairy, whole fat dairy and their
ratio (ratioLF/WF), and risk of mortality from coronary heart disease (CHD), stroke or
combined CVD. There were 548 recorded cases of CVD mortality in this cohort. For total
dairy intake, a reduction in risk of CVD was only seen in tertile 2 (adjusted hazard ratio,
AHR: 0.71; 95% CI: 0.55–0.93), and for CHD both tertile 2 and tertile 3 were associated
with a reduced risk (both with AHR: 0.71). However there were no linear trends between
total dairy consumption and any of the three outcomes. There were no associations or
trends between low/reduced fat dairy or whole fat dairy consumption, or ratioLF/WF and any
of the three outcomes in the fully adjusted model (all p > 0.05). This study found no
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consistent association between baseline consumption of dairy foods and the risk of CHD,
stroke and combined CVD mortality.
Keywords: dairy; cardiovascular disease; older Australian; Blue Mountains Eye
Study; population

1. Introduction
There is growing interest in the potential health benefits of dairy foods beyond bone health. Many
studies have explored the health benefits offered by regular dairy consumption [1–4], with potential
protective effects on the heart one of the most frequently investigated benefits [5–7].
Since dairy foods, particularly the whole fat varieties, are naturally high in saturated fat [8], intake
of dairy foods was initially believed to increase the risk of cardiovascular disease (CVD). This was
hypothesized because high saturated fat intake was shown to increase serum LDL cholesterol [9], a
strong risk factor for CVD. Recommendations were therefore developed to limit or replace whole fat
dairy products with low fat or skimmed varieties [10].
Prospective cohort studies [5–7,11] attempting to link dairy intake with risk of incident CVD,
however, identified mixed outcomes. An earlier systematic review published in 2001 concluded that
current clinical and biomedical evidence supports the hypothesis that dairy consumption may reduce
the risk of stroke [12]. Another systematic review of 12 prospective cohort studies published in 2009
concluded that there was no consistent evidence associating dairy foods with the risk of coronary heart
disease (CHD) [13]. A meta-analysis of 38 prospective cohort studies published in 2010 investigating
dairy consumption found significant reductions in risk of ischemic heart disease and stroke for subjects
with the highest dairy consumption [14]. However, another meta-analysis of 17 studies published in
2011 reported that milk intake was only modestly inversely associated with overall CVD risk, and
there was no significant association between milk consumption and all-cause mortality, or risk of CHD
or stroke [15]. Similarly, studies investigating the association between dairy consumption and CVD
mortality have reported mixed results [6,13,16–19], with some studies reporting a small protective
effect and others reporting no effect.
A previous study by our group [4] in a cohort of Australian aged 49 years or older (the Blue
Mountain Eye Study; BMES) had shown that higher whole fat dairy intake was associated with
reduced risk of metabolic syndrome but not type 2 diabetes, and higher low/reduced fat dairy intake
was associated with an increased risk of metabolic syndrome. Because metabolic syndrome is a
risk factor of CVD mortality, we aimed in this study to investigate the effect of habitual dairy
consumption on the risk of 15-year mortality from CVD, including CHD and stroke using data from
the BMES.
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2. Methods
2.1. Study Population
The BMES is a population-based cohort study of vision, common eye diseases and other health
outcomes in residents aged 49 years and over in the Blue Mountains area, west of Sydney, Australia [20].
During 1992–1994, of 4433 eligible residents aged 49–97 years, 3654 people attended detailed clinical
examinations, and 3267 participants (89.4%) attempted and returned the baseline food frequency
questionnaire (FFQ), of which 2900 were usable (79.4% of the participants examined).
This study was conducted according to guidelines from the Declaration of Helsinki and all
procedures involving human subjects/patients were approved by the Sydney West Area Health Service
and University of Sydney Human Research Ethics Committees. Written, informed consent was
obtained from all subjects.
2.2. Dietary Assessment
Dietary data were collected using a 145-item self-administered semi-quantitative FFQ, modified for
the Australian diet and vernacular from an early FFQ by Willett et al. [21]. Respondents were asked to
indicate their usual frequency of consuming food items during the past year, using a nine-category
frequency scale that ranged from never to four or more times per day. Each food was presented on the
FFQ with a standard portion size. An allowance for seasonal variation of fruit and vegetables was
made by weighting seasonal fruits and vegetables. Dietary intakes were reassessed by the same FFQ
every 5 years. The FFQ has been tested for reproducibility and validity in a subsample of the study
population against weighed food records for nutrients but not individual food items [22].
The Spearman correlation coefficient between FFQ and weighed food record for total calcium was
0.61 with less than 1% of the subjects grossly misclassified which indicates good validity. The
Spearman correlation coefficient for long-term reproducibility for total calcium is 0.69 which indicates
good reproducibility.
Nutrient intakes were estimated using the Australian Tables of Food Composition (NUTTAB90) [23]
for baseline dietary data. Dairy sub-categorization includes whole fat milk, reduced fat/skim milk, low
fat cheese, whole fat cheese, reduced fat dairy dessert (e.g., low fat yoghurt), and medium fat dairy
dessert (e.g., custard and whole fat yoghurt). In Australia the term whole fat dairy products does not
include high fat dairy products such as cream and butter. For the purpose of this analysis, total dairy
included all of dairy foods; low/reduced fat dairy included ―reduced fat/skim milk‖, ―reduced fat dairy
dessert‖ and ―low fat cheese‖; while whole fat dairy included ―whole fat milk‖, ―whole fat cheese‖ and
―medium fat dairy dessert‖. Tertiles of dairy product consumption were based on serves of dairy
consumed per day. The serving sizes used were 250 mL for milk, 200 g for yoghurt, 250 mL for
custards, and 40 g for cheeses based on the Australian Guide to Healthy Eating [10]. Buttermilk,
flavored milk and cream cheese were not included in the FFQ items, but they were not expected to be
consumed in large quantity by this population based on previous data [24]. A detailed list of the
number of questions asked for all dairy categories, as well as food categories used in the analyses is
available as Supplemental Table S1.
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2.3. Collection and Definition of Covariates
Weight and height of the participants were measured at each study visit. Physical activity was
assessed using a standardized interviewer-administered questionnaire as previously described [20].
History of smoking was defined as ―never‖, ―past‖, or ―currently smoking‖, which included those who
had stopped smoking within the past year. Blood pressure (BP) and fasting blood glucose level (FBG)
were assessed during each visit. Stage II hypertension was defined as systolic BP ≥ 160 mmHg and/or
diastolic BP ≥ 100 mmHg, or if subjects were previously diagnosed as hypertensive and were currently
using anti-hypertensive medications. Type 2 diabetes mellitus (T2DM) was defined as self-reported
diagnosis of T2DM and taking medication for T2DM, or FBG ≥ 7.0 mmol/L. Previous history of
stroke, angina and acute myocardial infarction were defined using self-reported physician diagnosis.
Participants self-reported their use of medications, and were instructed to bring all medications with
them at each visit for study personnel to check.
2.4. Definitions of the Health Outcomes of Interest
CVD mortality data were obtained by matching the causes of death by CHD or stroke to the
National Death Index (NDI), for approximately 95% of the participants up until 31 December 2007
(i.e., 15 years of follow up). Those who were unable to be matched to the NDI were excluded from the
analysis. Causes of death in the NDI were defined using the 9th revision of International Classification
of Diseases Code (ICD-9) and International Statistical Classification of Diseases, 10th revision
(ICD-10), with the following codes used for CHD: (ICD-9:410.0 to 410.9, 411.0 to 411.8, 412.0, 414.0
to 414.9 and ICD-10:I21.0 to I21.9, I22.0 to I22.9, I23.0 to I23.8, I24.0 to I24.9 and I25.0 to I25.9) or
stroke: (ICD-9:430.0 to 438.9 and ICD-10:I60.0 to I69.9). The data from Australian NDI has been
validated, and reported to be highly sensitive and specific for cardiovascular mortality (92.5% and
89.6%, respectively) [25]. The CVD cases combine the data for CHD and stroke, and there were
60 cases where CHD and stroke were both the primary cause of death.
2.5. Study Sample
The details of the data cleaning process have been reported elsewhere [26]. In brief subjects with
excessive missing FFQ data (>10% questions unanswered or missing data for all questions relating to a
particular food group), extreme nutrient values or extreme reported energy intake (<2500 kJ or
>18000 kJ per day) were excluded. On the basis of the above criteria, we excluded 367 FFQs at
baseline, leaving 2896 subjects with usable FFQ. For multivariate analyses with dairy intake variables
as the exposure variable, an additional 238 subjects were excluded due to unidentifiable causes of
death or missing baseline data for one or more of the following variables: BMI (41 missing values),
smoking status (83 missing values), and history of stroke (13 missing values), myocardial infarction
(15 missing values), or type 2 diabetes mellitus (125 missing values), reducing the number of subjects
to 2662. For multivariate analyses with ratioLF/WF as the exposure variable, a further 37 subjects
were excluded because of zero whole fat dairy intake resulting in division of zero in the calculation
of ratioLF/WF.
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2.6. Statistical Analyses
All statistical analyses were performed using Statistical Analysis System version 9.1 (SAS Institute,
Cary, NC). Cox proportional hazards regression models were used to investigate the associations
between tertiles of total, whole fat and low/reduced fat dairy consumption and the ratio of low/reduced
fat dairy to whole fat dairy (ratioLF/WF) at baseline, and risk of mortality from CHD, stroke or CVD.
Risk estimates were adjusted for known risk factors for cardiovascular mortality. The base model
included adjustment for age and sex. Further adjustment for total energy intake, body mass index
(BMI), change in weight during follow up, previous acute myocardial infarction, previous stroke,
smoking status, stage II hypertension at baseline and type 2 diabetes status at baseline, use of
hypertensive medications and statins, and change in dairy intake were made to Model 1, which was
used as the fully adjusted model. Change in dairy intake was calculated as dairy intake reported at
second study visit less that at first study visit; if the subject died before the second study visit, change
in dairy intake was set as 0; for analyses of total dairy, change in total dairy intake was included in the
model; for analyses of low/reduced fat dairy and whole fat dairy, change in both types of dairy were
included in the model; for analysis of ratioLF/WF, change in ratioLF/WF was included in the model.
Collinearity between the dairy intake variables and the change in dairy intake variables were examined
using the variance inflation factor (VIF) test and all of the VIF were found to be below 1.5, which is
much lower than the acceptable limit of 10, indicating a low possibility of collinearity. Other dietary
parameters (including intake of fish, fruit and vegetables) and socioeconomic status were not included
in the final model as these were not significant in any of the models tested. There was no interaction
between BMI and dairy intake and hence we did not stratify the analyses by BMI.
3. Results
The mean age of the study population at baseline was 65.4 (±SD 9.3) years. During the 15-year
follow up, 1048 cases of all-cause mortality were recorded, of which 432 cases were attributable to
CHD, and 176 to stroke and 548 to combined CVD. The mean daily total dairy intake of the study
population was 1.7 (±SD 1.2) serves, which includes 1.1 (±SD 1.0) serves of milk, 0.4 (±SD 0.5) serves
of cheese and 0.1 (±SD 0.3) serves of yoghurt. Due to the low reported intake of cheese and yoghurt,
we were unable to undertake a separate analysis on the individual dairy food types. There were 0.4%
non-consumers for total dairy, 1.4% non-consumers for full fat dairy, and 27.6% non-consumers for
low/reduced fat dairy in the study population, and no subjects in T2 and T3 had zero intakes or
ratioLF/WF. Table 1 shows the characteristics of the participants at baseline by tertiles of dairy intake.
Participants who had higher total dairy intake had higher energy, calcium, sodium, total fat and
saturated fat intake (all Ptrend < 0.001). Similar trends existed for tertiles of whole fat dairy
consumption and there were more smokers (Ptrend = 0.006) and male participants in the higher tertiles
(Ptrend < 0.001). For low/reduced fat dairy, there were less male participants (Ptrend < 0.001) and
smokers (Ptrend < 0.001) in the higher tertiles. Those who had more low/reduced fat dairy also tended to
be younger (P < 0.001), had higher BMI, energy intake and calcium intake (all Ptrend < 0.001), but had
lower intakes of total fat and saturated fat (all Ptrend < 0.001).
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Table 1. Subject characteristics at baseline by tertiles of dairy intake. Values are mean ± SD
except for male and smoker, which were given as percentages. * p for trend, except for
categorical variables which were tested by Pearson’s χ2. BMI, Body Mass Index; AMI,
acute myocardial infarction; RatioLF/WF, Ratio between low fat dairy and whole fat dairy.
T1

T2

T3

p value *

Age (year)

65.5 ±9.4

65.3 ±9.4

65.2 ±9.1

0.760

Male (%)

47.0

43.7

41.5

0.053

Total dairy

Smokers (%)

15.8

12.9

13.5

0.168

BMI (kg/m2)

26.0 ±4.6

26.1 ±4.4

26.4 ±4.3

0.231

Energy (kJ)

7340.7 ±2324.7

8449.0 ±2280.0

9780.7 ±2518.0

<0.001

517.4 ±172.2

809.8 ±158.3

1345.4 ±338.0

<0.001

Total fat (g)

64.2 ±25.5

75.3 ±24.9

88.6 ±31.2

<0.001

Saturated fat (g)

23.8 ±11.0

29.3 ±11.1

36.4 ±15.0

<0.001

Fish intake (g)

25.6 ±27.1

27.1 ±28.0

29.6 ±2.79

0.005

Fruit intake (g)

303.8 ±283.7

329.1 ±230.2

395.0 ±260.6

<0.001

Vegetable intake (g)

Calcium (mg)

408.2 ±200.9

439.2 ±180.7

477.7 ±197.8

<0.001

Previous AMI (%)

8.3

8.4

8.7

0.952

Previous stroke (%)

4.7

4.7

4.8

0.990

Previous angina (%)

11.5

11.6

11.8

0.982

Type 2 diabetes (%)

5.5

7.8

9.3

0.007

Stage II hypertension (%)

47.5

45.2

43.2

0.165

Using anti-hypertensive drug (%)

43.1

41.9

38.1

0.646

Using statins (%)

3.7

3.0

3.3

0.674

Education level: degree or above (%)

57.4

60.0

61.9

0.147

Age (year)

66.8 ±9.9

64.3 ±9.3

65.1 ±8.6

<0.001

Male (%)

54.3

43.1

35.3

<0.001

Low/reduced fat dairy

Smokers (%)

19.1

14.3

9.2

<0.001

BMI (kg/m2)

25.6 ±4.3

26.5 ±4.5

26.3 ±4.4

<0.001

Energy (kJ)

8599.0 ±2658.3

8224.0 ±2654.5

8744.2 ±2389.8

<0.001

746.0 ±360.0

755.7 ±326.8

1158.1 ±414.5

<0.001

Total fat (g)

80.6 ±29.6

74.9 ±30.3

72.8 ±26.8

<0.001

Saturated fat (g)

33.1 ±14.2

29.1 ±13.6

27.4 ±12.1

<0.001

Fish intake (g)

23.6 ±26.7

27.8 ±26.6

30.7 ±29.2

<0.001

Fruit intake (g)

293.2 ±260.6

341.8 ±252.1

389.8 ±263.9

<0.001

Vegetable intake (g)

Calcium (mg)

423.3 ±202.2

437.9 ±195.3

462.8 ±186.8

<0.001

Previous AMI (%)

6.5

7.9

10.9

0.001

Previous stroke (%)

5.5

3.5

5.1

0.096

Previous angina (%)

9.0

11.1

14.7

<0.001

Type 2 diabetes (%)

6.5

7.7

8.4

0.292

Stage II hypertension (%)

45.7

44.8

45.4

0.925

Using anti-hypertensive drug (%)

40.9

38.7

43.5

0.098

Using statins (%)

1.4

3.3

5.2

<0.001

Education level: degree or above (%)

54.7

64.3

59.8

0.002
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Whole fat dairy
Age (year)

65.0 ±8.8

65.4 ±9.2

65.7 ±9.9

0.327

Male (%)

39.3

43.8

49.2

<0.001

Smokers (%)

14.4

11.3

16.5

0.006

BMI (kg/m2)

26.3 ±4.5

26.1 ±4.5

26.2 ±4.4

0.706

Energy (kJ)

7460.7 ±2198.7

8377.2 ±2404.6

9742.3 ±2582.2

<0.001

731.1 ±383.2

835.3 ±373.1

1106.9 ±399.7

<0.001

Total fat (g)

60.4 ±23.0

73.9 ±25.0

94.0 ±28.5

<0.001

Saturated fat (g)

21.3 ±9.6

28.4 ±10.6

39.8 ±13.0

<0.001

Fish intake (g)

28.5 ±30.3

27.7 ±26.0

26.1 ±26.5

0.150

Fruit intake (g)

340.3 ±280.2

337.1 ±247.0

350.3 ±257.0

0.513

Vegetable intake (g)

420.3 ±190.3

443.7 ±191.9

461.4 ±201.7

<0.001

Previous AMI (%)

11.8

7.2

6.4

<0.001

Previous stroke (%)

5.5

4.0

4.6

0.287

Previous angina (%)

14.9

10.9

9.1

<0.001

Type 2 diabetes (%)

7.4

6.0

9.2

0.034

Stage II hypertension (%)

50.0

43.3

42.5

0.001

Using anti-hypertensive drug (%)

48.6

38.5

35.9

<0.001

Using statins (%)

5.6

3.0

1.3

<0.001

Education level: degree or above (%)

58.0

59.9

38.9

0.393

Age (year)

65.6 ±9.9

64.5 ±9.3

65.0 ±8.7

0.327

Male (%)

54.0

42.5

35.8

<0.001

19.3

13.2

10.2

<0.001

Calcium (mg)

RatioLF/WF

Smokers (%)
2

BMI (kg/m )

25.6 ±4.2

26.6 ±4.6

26.3 ±4.3

0.706

Energy (kJ)

8791.7 ±2642.3

8672.2 ±2746.2

8191.9 ±2266.6

<0.001

797.2 ±370.2

874.6 ±432.8

1007.1 ±410.8

<0.001

Total fat (g)

83.1 ±29.9

79.9 ±30.2

66.2 ±23.5

<0.001

Saturated fat (g)

34.5 ±14.3

31.5 ±13.4

24.0 ±10.1

<0.001

Fish intake (g)

23.8 ±25.8

28.0 ±26.7

29.8 ±26.7

0.150

Fruit intake (g)

298.5 ±257.7

360.6 ±263.0

371.1 ±260.8

0.513

Vegetable intake (g)

425.5 ±196.3

455.0 ±203.7

447.0 ±182.5

<0.001

Previous AMI (%)

6.0

7.0

12.0

<0.001

Previous stroke (%)

5.4

3.6

5.3

0.119

Previous angina (%)

8.6

9.9

16.0

<0.001

Type 2 diabetes (%)

6.8

8.4

7.2

0.417

Stage II hypertension (%)

45.3

42.8

47.5

0.112

Using anti-hypertensive drug (%)

40.7

36.1

46.2

<0.001

Using statins (%)

13.8

26.6

59.6

<0.001

Education level: degree or above (%)

54.3

64.8

60.0

<0.001

Calcium (mg)
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Table 2. Hazard Ratio † (95% Confidence Interval) of cardiovascular disease mortality according to tertiles of dairy intake. CVD,
cardiovascular disease; IQR, interquartile range; RatioLF/WF, ratio between low fat dairy and whole fat dairy. # The serving sizes used were
250 mL for milk, 200 g for yoghurt, 250 mL for custards, and 40 g for cheeses; † Hazard ratios calculated by Cox proportion hazard
regression; ‡ Base model adjusted for age and sex; § Model 1: Base model with additional adjustment for total energy, baseline BMI, change in
weight during follow up (kg), physical activity level (METs), previous acute myocardial infarction (yes/no), previous stroke (yes/no), smoking
status (yes/no), stage II hypertension (yes/no), type 2 diabetes status (yes/no), use of antihypertensive medication (yes/no), use of statins
(yes/no) and change in dairy intake; * p < 0.05 when compared to tertile 1.

Total dairy
(serves/day) #

T1
(ref)
T2
T3

Low/reduced
fat dairy
(serves/day)

ptrend
T1
(ref)
T2
T3

Whole fat
dairy
(serves/day)

ptrend
T1
(ref)
T2
T3

RatioLF/WF

ptrend
T1
(ref)
T2
T3
ptrend

n

Median (IQR)

965 ‡
879 §
967 ‡
883 §
964 ‡
900 §
934 ‡
841 §
968 ‡
892 §
994 ‡
929 §
977 ‡
901 §
952 ‡
883 §
967 ‡
878 §
952 ‡
856 §
952 ‡
881 §
952 ‡
888 §
-

0.6
(0.3–0.9)
1.4
(1.2–1.6)
2.9
(2.4–3.3)
0.0
(0.0–0.0)
0.1
(0.1–0.5)
1.2
(1.0–2.5)
0.1
(0.1–0.3)
0.8
(0.5–0.8)
1.8
(1.3–2.6)
0.0
(0.0–0.0)
0.3
(0.1–0.8)
5.6
(2.9–12.0)
-

Total CVD
Deaths Base model ‡
197 ‡
1.00
176 §
175 ‡
0.81 *
158 § (0.66–0.99)
176 ‡
0.90
157 § (0.73–1.10)
0.762
222 ‡
1.00
192 §
155 ‡
0.81 *
143 § (0.65–0.99)
171 ‡
0.87
156 § (0.71–1.07)
0.756
179 ‡
1.00
164 §
177 ‡
0.95
162 § (0.77–1.17)
192 ‡
0.92
165 § (0.75–1.13)
0.809
220 ‡
1.00
192 §
160 ‡
0.84
145 § (0.68–1.03)
161 ‡
0.85
148 § (0.69–1.05)
0.589

Model 1 §
1.00
0.71 *
(0.55–0.93)
0.76
(0.56–1.02)
0.500
1.00
0.89
(0.68–1.05)
0.80
(0.61–1.06)
0.205
1.00
1.03
(0.80–1.34)
0.86
(0.64–1.16)
0.362
1.00
0.88
(0.63–1.24)
0.94
(0.68–1.31)
0.396

Stroke
Deaths Base model ‡
56 ‡
1.00
50 §
63 ‡
0.99
58 §
(0.69–1.42)
57 ‡
1.01
50 §
(0.70–1.46)
0.464
75 ‡
1.00
64 §
49 ‡
0.76
45 §
(0.53–1.09)
52 ‡
0.78
49 §
(0.54–1.13)
0.777
53 ‡
1.00
49 §
52 ‡
0.94
49 §
(0.64–1.38)
71 ‡
1.13
60 §
(0.79–1.62)
0.065
74 ‡
1.00
64 §
56 ‡
0.87
51 §
(0.61–1.23)
42 ‡
0.65 *
39 §
(0.44–0.96)
0.130

Coronary Heart Diseases
Model 1 § Deaths Base model ‡ Model 1 §
1.00
159 ‡
1.00
1.00
143 §
0.86
136 ‡
0.78 *
0.71 *
(0.53–1.40) 123 § (0.62–0.99) (0.53–0.96)
0.98
137 ‡
0.87
0.71 *
(0.58–1.16) 122 § (0.69–1.09) (0.51–0.99)
0.775
0.974
0.318
1.00
172 ‡
1.00
1.00
149 §
1.00
120 ‡
0.80
0.84
(0.63–1.59) 112 § (0.63–1.01) (0.62–1.13)
0.84
140 ‡
0.92
0.87
(0.52–1.37) 127 § (0.73–1.16) (0.64–1.18)
0.434
0.916
0.659
1.00
146 ‡
1.00
1.00
133 §
1.02
146 ‡
0.96
1.03
(0.64–1.64) 134 § (0.77–1.21) (0.77–1.37)
1.01
140 ‡
0.83
0.77
(0.64–1.64) 121 § (0.66–1.05) (0.55–1.08)
0.980
0.170
0.148
1.00
170 ‡
1.00
1.00
149 §
1.08
120 ‡
0.81
0.83
(0.60–1.96) 109 § (0.64–1.03) (0.57–1.22)
0.81
137 ‡
0.94
1.04
(0.44–1.49) 126 § (0.75–1.18) (0.72–1.49)
0.255
0.814
0.993
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Table 2 shows the hazard ratios of combined CVD, stroke and CHD mortality according to tertiles
of baseline dairy intake. Subjects whose total dairy intake was in tertile 2 had a 29% decreased risk of
total CVD mortality in the fully adjusted model (multivariate adjusted HR: 0.71; 95% CI: 0.55–0.93).
When split into subtypes of CVD, higher total dairy intake was found to be associated with a lower
risk of CHD but not stroke. The reduction in CHD risk appeared to be equal (29% decreased risk) for
those whose dairy intake was in tertiles 2 and 3. There were no significant linear trends between total
dairy consumption and any of the three outcomes in both the base model and the fully adjusted model.
We also examined non-linear trend for total CVD mortality across total dairy tertile and found there
was no significant U-shaped relationship between total dairy intake and total CVD mortality (p = 0.080
in Model 1 with dairy intake entered as a quadratic term). No associations between low/reduced fat or
whole fat dairy consumption and ratioLF/WF and any of the three outcomes were seen in the fully
adjusted model. Excluding prevalent CVD cases at baseline did not affect the results. Because of the
high proportion of non-consumers for low/reduced fat dairy, we have conducted an additional analysis
using the combined T1 and T2 for low/reduced fat dairy as a referent group, and found the HR for T3
to be similar (data not shown).
4. Discussion
Although the association between habitual dairy consumption and the risk of CVD mortality had
been studied previously by many other groups [14,15,27], these results have been inconsistent. The
present study is one of only few studies investigating such associations in an older population. We
found that in a population-based cohort of older Australians, those with a medium intake (middle tertile)
of total dairy had a significantly reduced risk of combined CVD mortality, and those with medium to
high intakes (middle and upper tertiles) had a reduced risk of CHD mortality. It is however difficult to
interpret these findings in the middle tertile and to determine whether it represents a true protective
effect or are chance findings. There were no significant trends evident between increasing habitual
dairy consumption (regardless of type) and the risk of CHD, stroke or combined CVD mortality.
Nonetheless, there was no indication that increased dairy intake, even whole fat dairy, was associated
with any increased risk of CVD in older subjects.
The Australian Guide to Healthy Eating (AGHE) recommends the consumption of 2 to 3 serves of
dairy products per day to achieve a nutritionally adequate diet [10]. The study population reported a
mean total dairy intake of 1.7 serves per day, which is less than the AGHE recommendation. This is
comparable to the Australian national consumption data [24] and that reported by Bonthuis et al. [27]
among Australian adults, despite the difference in dietary assessment method, comparing the FFQ to
24 h recall data. Bonthuis et al. [27] however reported different findings to the present study, where a
strong protective effect was found for 16 year CVD mortality, but only in whole fat dairy
(69% decreased risk for tertile 3 vs. tertile 1; Ptrend = 0.04). Subjects in that study, however, had a much
wider age range (25–78 years) than those of our study, which could explain the discrepancies, as
the effect of dairy consumption and the pattern of dairy intake could differ between younger and
older populations.
Previous studies suggested that dairy consumption was protective for incident stroke. In the
Caerphilly cohort study [7], 665 men aged 45–59 years were followed for 20 years. The authors reported
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that participants whose daily milk intake was at or above the median intake (187 mL) were 48%
(95% CI: 1%–73%; P = 0.05) less likely to experience a stroke incident. The study by Abbott et al. [28]
also showed a reduction in rate of stroke with increasing milk intake (P < 0.05)—compared to
non-milk drinkers, subjects who consumed at least 16 oz (448 mL) of milk per day were more than two
times less likely to experience stroke (7.9% vs. 3.7%). The Alpha-Tocopherol, Beta-Carotene Cancer
Prevention Study [29], on the other hand, showed no association between total dairy, low fat milk or
regular milk consumption and the risk of most types of stroke, except for subjects who had the highest
regular milk consumption (median intake 850 g/day), where a 41% increased risk (P < 0.05) of
contracting intracerebral hemorrhage was found.
There is also evidence to support the protective effect of dairy calcium intake on stroke mortality.
The Japan Public Health Center (JPHC) study [30] showed that, compared to those with the lowest
dairy calcium intake (median = 0 mg/day), individuals who had the highest dairy calcium intake
(median = 116 mg/day) had a 30% reduced risk for mortality from both total stroke and ischemic
stroke (both P < 0.05). Similar results were reported by the same group earlier using data from the
Japan Collaborative Cohort (JACC) study [31], which reported a 47% reduction in risk of mortality
from both total stroke and ischemic stroke (both P < 0.05) among those people who had the highest
dairy calcium intake (median = 127 mg/day). That study also reported a 27% (P < 0.05) reduced risk
of mortality from combined CVD for those in the highest quintile of dairy calcium intake compared to
those in the lowest quintile.
Evidence from studies investigating the association between dairy consumption and CVD mortality,
however, is inconsistent. Three studies [16–18] reported no consistent association between dietary or
dairy calcium intake and the risk of IHD mortality. Ness et al. [6] found no association between self
reported daily milk intake at baseline and the risk of CHD, stroke or combined CVD mortality among
5765 men aged 35–64 years at baseline. The Rotterdam study [32] reported similar findings in
4664 adults aged ≥55 years. Similarly, the present study did not found significant trends between
habitual dairy consumption and risk of CHD, stroke or combined CVD mortality.
Studies that examined the effect of individual dairy products or ratio between whole fat and reduced
fat dairy have produced different results. In the study by Mann et al. [33], while they found no
association between the risk of IHD mortality and daily intake of milk, there was a significantly
increasing trend in risk for higher cheese consumption. Similarly, while Hu et al. [34] found no
association between either low/reduced fat or high fat dairy intake and the risk of CHD mortality in
80,082 women aged 34–59 years, they found a significant increasing trend in risk of CHD for
increasing ratio between high fat and low/reduced fat dairy intake. We however did not find significant
associations between ratioLF/WF (an inverse ratio of what was used in the study by Hu et al. [34]) and
risk of CVD mortality.
In the same cohort [4] our group had previously shown that higher whole fat dairy intake was
associated with reduced risk of metabolic syndrome but not type 2 diabetes, and higher low/reduced fat
dairy intake was associated with an increased risk of metabolic syndrome. This is in contrast to the
findings of the present study where higher intakes of total or low/reduced fat dairy appeared to be
associated with a reduced risk of CVD mortality. The discrepancy of the finding could be due to the
higher specificity of CVD mortality as an outcome as compared to that of metabolic syndrome, which
is defined as a cluster of metabolic risk factors for CVD [35]. Subjects who met the criteria of
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metabolic syndrome do not necessarily develop CVD in the future—by definition they are only at a
higher risk of developing CVD. These subjects may have been advised on dietary/lifestyle changes to
reduce their risk of CVD. On the other hand, the time it takes for individuals at risk of CVD to
encounter a fatal CVD event also varies. Therefore it may be interesting to follow-up this cohort for a
longer period of time.
The strengths of the present study include the use of a validated FFQ with a high correlation
coefficient for calcium to assess the dairy intake of the participants. This is likely to increase the
plausibility of the associations found. The long follow up period also allowed us to better explore the
temporal relationship between dairy consumption and CVD mortality. In addition, the application of
the International Classification of Diseases Code results in accurate classification of the causes of
death [25]. Furthermore, while this cohort was set up to study risk factors for vision diseases, this
sample population is representative of the elderly Australian population except that the subjects had a
higher SES.
However, the present study was limited in several ways. We have not presented data on non-fatal
CVD as these were collected only via self-report, which had a high likelihood of report bias due to the
potential cognitive and memory impairment of the older population. In addition, subjects with a CVD
event are more likely to switch to a healthier diet, including the use of low/reduced fat dairy products,
although this was adjusted for in the model. While using more than one FFQ collected more frequently
(e.g., annually) may allow better detection in change in dairy consumption pattern, this would have
imposed a significant burden on the study participants, which could have affected the response rate,
and so was not adopted in the present study. We were also unable to rule out the effect of
residual confounding.
5. Conclusions
There was no consistent association between baseline consumption of dairy foods and the risk of
coronary heart disease, stroke and combined cardiovascular disease mortality.
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